human immunodeficiency virus associated wasting syndrome相关文献:
The treatment of human immunodeficiency virus-associated wasting syndrome with recombinant human growth hormone, then and now: a pivotal paper review.
PMID:
Role of acquired immune deficiency syndrome-defining conditions in human immunodeficiency virus-associated wasting.
PMID:
Weight Gain and Metabolic Syndrome in Human Immunodeficiency Virus Patients.
Chang HH.
Infect Chemother. 2022 Jun;54(2):220-235. doi: 10.3947/ic.2022.0061. Epub 2022 May 31.
PMID:35706080
HIV-associated wasting.
Keithley JK, Swanson B.
J Assoc Nurses AIDS Care. 2013 Jan-Feb;24(1 Suppl):S103-11. doi: 10.1016/j.jana.2012.06.013.
PMID:23290370
The etiology of wasting in the human immunodeficiency virus and acquired immunodeficiency syndrome.
Strawford A, Hellerstein M.
Semin Oncol. 1998 Apr;25(2 Suppl 6):76-81.
PMID:9625388
Human immunodeficiency virus-associated wasting and mechanisms of cachexia associated with inflammation.
Moldawer LL, Sattler FR.
Semin Oncol. 1998 Feb;25(1 Suppl 1):73-81.
PMID:9482543
A systematic review of sarcopenia prevalence and associated factors in people living with human immunodeficiency virus.
SeyedAlinaghi S, Ghayomzadeh M, Mirzapour P, Maroufi SF, Pashaei Z, Ali Z, Tantuoyir MM, Aghaie N, Vahedi F, Salmani R, MohsseniPour M, Qaderi K, Shahidi R, Peyman A, Varshochi S, Afzalian A, Maroufi SP, Mehraeen E, Dadras O, Hackett D.